Unfortunately, they're not from registry data.
They have a registry in the U.S., the NBIR, but it's a voluntary registry that's relatively new, and only about 30% of plastic surgeons use it.
If I understood correctly, basically on what happened, since they identified the ALCL, it's been a huge problem getting accurate numbers from the breast implant companies. They were just able to tell us, “Well, this is how many implants we sold.”
It's not clear what the numerator and the denominator are. What ended up happening was that one plastic surgeon in particular in New York, Peter Cordeiro, who was doing all his breast reconstructions with textured Allergan implants, collected his own data. He had great follow-up with his patients. Those numbers are coming primarily from him, and he's found that the incidence is as high as one in 100 with his patients.